The injections are painless
The drugs enhanced participants motivation, but increased the amount of time they spent solving a problem by 50%, with scientists saying they spent almost as much time on the easiest instances under MPH as on the hardest instances under a placebo, without any corresponding improvement in performance. While under the prescriptive stimulants, scientists reported peoples efforts increased while the quality of their efforts decreased, meaning they did more, but their decisions were not as calculated as they were random
Overall, combining an SGLT2i and a GLP-1 RA may provide a holistic approach to improving outcomes in patients with CKD and high CV risk [100]
The story of modern CVOTs begins with the 2008 FDA guidance, prompted by concerns over rosiglitazone's potential cardiovascular harm, requiring new antidiabetic agents to demonstrate cardiovascular safety (non-inferiority for 3-point MACE) [34]
By route of administration, the oral GLP-1 market is expected to witness a faster growth during 20262034